Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Highlights Results From Six Preclinical Abstracts at the American Association for Cancer Research Annual Meeting 2015
April 21, 2015 07:45 ET | Calithera Biosciences, Inc.
-Potential Biomarker Response to CB-839 Among KRAS and EGFR Mutant Cell Lines -Synergy of CB-839 with Signal Transduction Pathways SOUTH SAN FRANCISCO, Calif., April 21, 2015 (GLOBE NEWSWIRE) --...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the 14th Annual Needham Healthcare Conference
April 09, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 9, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports Fourth Quarter and Full Year 2014 Financial Results and Recent Highlights
March 26, 2015 16:05 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 26, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Report Fourth Quarter and Year-End 2014 Financial Results on Thursday, March 26, 2015
March 20, 2015 08:30 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 20, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Announces Five Data Presentations at the American Association for Cancer Research Annual Meeting 2015
March 18, 2015 16:29 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Gains Exclusive, Worldwide License to TransTech Pharma's Hexokinase II Inhibitor Program
March 05, 2015 16:02 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 5, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Present at the BIO CEO & Investor and Leerink Global Healthcare Conferences in February
February 03, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development
January 30, 2015 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition in Tumor Biopsy Samples From Patients Treated With CB-839
December 10, 2014 13:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer agents,...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Gains Exclusive, Worldwide License to Mars Symbioscience's Arginase Inhibitors
December 09, 2014 09:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 9, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) announced today the signing of an exclusive global license agreement with Mars...